The Living Guidelines: Diagnosis and Management of Atrial Fibrillation: Difference between revisions

	WikiDoc Resources for The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Articles
Most recent articles on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Most cited articles on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Review articles on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Articles on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Images of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Photos of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Podcasts & MP3s on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Videos on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Evidence Based Medicine
Cochrane Collaboration on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Bandolier on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation TRIP on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Clinical Trials
Ongoing Trials on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation at Clinical Trials.gov Trial results on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Clinical Trials on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation NICE Guidance on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation NHS PRODIGY Guidance FDA on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation CDC on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Books
Books on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
News
The Living Guidelines: Diagnosis and Management of Atrial Fibrillation in the news Be alerted to news on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation News trends on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Commentary
Blogs on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Definitions
Definitions of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Patient Resources / Community
Patient resources on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Discussion groups on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Patient Handouts on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Directions to Hospitals Treating The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Risk calculators and risk factors for The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Healthcare Provider Resources
Symptoms of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Causes & Risk Factors for The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Diagnostic studies for The Living Guidelines: Diagnosis and Management of Atrial Fibrillation Treatment of The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Continuing Medical Education (CME)
CME Programs on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
International
The Living Guidelines: Diagnosis and Management of Atrial Fibrillation en Espanol The Living Guidelines: Diagnosis and Management of Atrial Fibrillation en Francais
Business
The Living Guidelines: Diagnosis and Management of Atrial Fibrillation in the Marketplace Patents on The Living Guidelines: Diagnosis and Management of Atrial Fibrillation
Experimental / Informatics
List of terms related to The Living Guidelines: Diagnosis and Management of Atrial Fibrillation

	Atrial fibrillation;
ICD-10	I48
ICD-9	427.31
DiseasesDB	1065
MedlinePlus	000184
eMedicine	med/184 emerg/46

VisualWikitext

Revision as of 20:16, 15 June 2009

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

@@ Line 140: / Line 140: @@
 [[The Living Guidelines: Pharmacological Cardioversion of Atrial Fibrillation: Suggest Revisions to the CLASS III Guidelines|Suggest Revisions to the Guidelines]]
-==Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter <small><ref name="Epstein"> Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: 2820–2840. PMID 18483207 </ref></small>==
+==Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter <small><ref name="Fuster"> Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation- Executive Summary: executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidlines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006; 114: 700-752. PMID 16908781 </ref></small>==
 ===Class I===

Atrial fibrillation
ICD-10	I48
ICD-9	427.31
DiseasesDB	1065
MedlinePlus	000184
eMedicine	med/184 emerg/46

v t e Electrocardiography
Overview	History of the EKG • EKG interpretation basics • Normal sinus rhythm
EKG Complexes	P wave • QRS complex • ST Segment • T wave • T wave alternans • Tombstone T wave • U wave Osborn wave • H wave • K wave • Delta wave NSSTW changes
EKG Intervals	PR Interval • QRS Interval • ST Interval • QT Interval
Conduction System & Bradycardia	Cardiac pacemaker • SA node • AV node• Bundle of His • Purkinje fibers • Sinus bradycardia • First Degree AV Block • Second Degree AV Block • Complete or Third-Degree AV Block • Concealed conduction • AV Junctional Rhythms • LBBB • LAHB • LPHB • RBBB • Trifascicular block
Atrial Arrhythmias	Sinus tachycardia • Premature Atrial Contractions (PACs) • Ectopic Atrial Rhythm • Paroxysmal Atrial Tachycardia (PAT) • Paroxysmal Atrial Tachycardia (PAT) with Block • Multifocal Atrial Tachycardia (MAT) • Atrial Flutter • Atrial Fibrillation • Wandering atrial pacemaker
Ventricular Arrhythmias	Differential Diagnosis of Tachycardia with a Wide QRS Complex • Accelerated Idioventricular Rhythm • Ventricular Parasystole • Premature Ventricular Contractions (PVCs) • Ventricular tachycardia • Ventricular Fibrillation • Sudden cardiac death
EKG Abnormalities in Disease States	Hypertrophy & Dilatation • Right atrial enlargement • Left atrial enlargement • Biatrial enlargement • Left Ventricular Hypertrophy • Right Ventricular Hypertrophy • Biventricular Hypertrophy • Acute myocardial infarction • NSTEMI • STEMI • Tombstone ST elevation • Right ventricular myocardial infarction • Atrial infarction Pre-excitation Syndromes • Wolff-Parkinson-White Syndrome • Lown Ganong Levine Syndrome • Mahaim Type Preexcitation Cardiomyopathies • Arrhythmogenic Right Ventricular Dysplasia • Dilated Cardiomyopathy • Hypertrophic Cardiomyopathy Drug Effects on the EKG • Adenosine • β-blockers • Digitalis • Quinidine • Procainamide • Disopyramide • Lidocaine • Tocainide and Mexiletine • Phenytoin • Encainide, Flecainide and Propafenone • Amiodarone • Bretylium • Ca Channel Blockers • Phenothiazines • Tricyclic Antidepressants • Lithium Congenital Heart Disease • Dextrocardia • Atrial Septal Defect • Ventricular Septal Defect • Tetralogy of Fallot • Conjoined Twins or Siamese Twins • Congenital heart block Electrolyte Disturbances • Hyperkalemia • Hypokalemia • Hypercalcemia • Hypocalcemia • Nonspecific Changes Other Heart Diseases • Pericarditis • Myocarditis • Tamponade • Heart Transplantation • Sick Sinus Syndrome • Long QT Syndrome Inherited Disease • Brugada Syndrome Systemic Diseases • CNS Disease • Cardiac Tumors Heart Transplantation • EKG Changes in patient with Heart Transplantation Exogenous Effects • Hypothermia • Chest Trauma • Insect Bites • Electric Injuries
Technical Issues and Potential Errors in Interpretation	Artifacts • Lead Placement Errors • The EKG in a Patient with a Pacemaker • EKG in athletes

The Living Guidelines: Diagnosis and Management of Atrial Fibrillation: Difference between revisions

Revision as of 20:16, 15 June 2009

Recommendations for pharmacological rate control during atrial fibrillation [1]

Class I

Class IIa

Class IIb

Class III

Recommendations for preventing thromboembolism [1]

Class I

Class IIa

Class IIb

Class III

Recommendations for pharmacological cardioversion of atrial fibrillation [1]

Class I

Class IIa

Class IIb

Class III

Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter [1]

Class I

Class IIa

Class III

Recommendation for pharmacological enhancement of direct-current cardioversion [2]

Class IIa

Class IIb

Recommendation for prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion [2]

Class I

Class IIa

Recommendations for maintenance of sinus rhythm [2]

Class I

Class IIa

Class III

Recommendations for patients with postoperative atrial fibrillation [2]

Class I

Class IIa

Class IIb

Recommendations for patients with acute myocardial infarction [2]

Class I

Class IIa

Class III

Recommendations for patients with Wolff Parkinson White syndrome (WPW) [2]

Class I

Class IIa

Class IIb

Class III

Recommendations for patients with hyperthyroidism [2]

Class I

Recommendations for pregnant patients [2]

Class I

Class IIb

Recommendations for patients with Hypertrophic Cardiomyopathy [2]

Class I

Class IIa

Recommendations for patients with Pulmonary Hypertension [2]

Class I

Class III

References

Navigation menu

Recommendations for pharmacological rate control during atrial fibrillation ^[1]

Recommendations for preventing thromboembolism ^[1]

Recommendations for pharmacological cardioversion of atrial fibrillation ^[1]

Recommendation for direct-current cardioversion of atrial fibrillation and atrial flutter ^[1]

Recommendation for pharmacological enhancement of direct-current cardioversion ^[2]

Recommendation for prevention of thromboembolism in patients with atrial fibrillation undergoing cardioversion ^[2]

Recommendations for maintenance of sinus rhythm ^[2]

Recommendations for patients with postoperative atrial fibrillation ^[2]

Recommendations for patients with acute myocardial infarction ^[2]

Recommendations for patients with Wolff Parkinson White syndrome (WPW) ^[2]

Recommendations for patients with hyperthyroidism ^[2]

Recommendations for pregnant patients ^[2]

Recommendations for patients with Hypertrophic Cardiomyopathy ^[2]

Recommendations for patients with Pulmonary Hypertension ^[2]